EyeCRO are Experts in preclinical efficacy studies in ophthalmic retinopathy, pharmacokinetics, both in vivo and in vitro for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in retina preclinical efficacy, oxygen-induced retinopathy, and ophthalmic pharmacokinetics for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in Laser CNV, Retina preclinical efficacy, and Ophthalmic toxicology for clinical and precise formulation services.

Web developed by Josh Bolinger website design

The Global Leader in Preclinical Ophthalmic Research

MiDROPS™

The Microemulsion Drug Ocular Penetration System (MiDROPS™) is a transformative technology for the development of eyedrop formulations.  This patented platform allows for the preparation and delivery of lipophilic agents to tissues in both the front and back of the eye.  MiDROPS™ are prepared using materials already approved by the US Food and Drug Administration for use in ophthalmic products, and by nature are intrinsically thermo-stable.

 

In-Vivo

EyeCRO provides numerous in-vivo research models to enable directed and meaningful preclinical drug discovery and development programs. EyeCRO also has extensive experience in various routes of administration and can customize studies depending on your needs. One of the main advantages in working with EyeCRO is our ability to be flexible.

Roche CEO ‘sleeps better’ as risk to drugmaker’s growth recedes

LONDON (Reuters) - Roche (ROG.S) is increasingly confident it will continue to lift sales and profit … Read More

Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration.

Retinal degenerative diseases are major causes of untreatable blindness, and novel approaches to … Read More

Prismatic eyewear for patients with tunnel vision to launch

A trio of eyeglasses using revolutionary prism techniques could open up a whole new field of view … Read More

More News

Wednesday, June 29th, 2016 at 8:43am
RT @SurgeonRetina: Pentazocine, pain reliever, rescues color sensing retinal cells in blindness model via @pnas https://t.co/blTBeYaQwr htt… EyeCRO photo
Wednesday, June 29th, 2016 at 8:43am
RT @PBA_savingsight: DYK: 19% of firework-related injuries are to the eyes? Find out more from @NFPA National Fire Protection Association h… EyeCRO photo
Tuesday, June 28th, 2016 at 4:58pm
From pain to floaters: 5 eye symptoms you should never ignore https://t.co/UfIZWL20EI via @todayshow
Ophthalmic Contract Research